Drug intelligence / Profile preview

cefazolin + cefuroxime + cefotaxime + ceftazidime + ceftriaxone + cefepime + Pre-Pen + penicillin G + ampicillin + histamine

Development stage
Unknown
Lead developer
GSK
Modality
Recombinant Proteins and Enzymes, Peptides, Small Molecules
Administration
Epicutaneous, Intradermal
01

Overview

This is a combination of multiple beta-lactam antibiotics (cefazolin, cefuroxime, cefotaxime, ceftazidime, ceftriaxone, cefepime—all cephalosporins; penicillin G and ampicillin—penicillins), Pre-Pen (benzylpenicilloyl polylysine used for allergy testing), and histamine. Such a mixture is not used therapeutically but may be employed in specialized diagnostic protocols for evaluating beta-lactam antibiotic allergies or hypersensitivity reactions. The antibiotics act by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs), leading to bacterial lysis. Pre-Pen is used as a major determinant in skin testing for IgE-mediated penicillin allergy. Histamine may be included as a positive control in skin testing procedures[5][7]. This combination does not represent an approved pharmaceutical product but rather components commonly involved in allergy evaluation.

Brand names
Pre-Pen
Other names
Cephalosporin Allergy Skin Testing PanelBeta-lactam Allergy Diagnostic Panel
02

Targets

HRH1 (Histamine H1 Receptor)benzylpenicilloyl-specific IgE (Benzylpenicilloyl-specific immunoglobulin E)PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on cefazolin + cefuroxime + cefotaxime + ceftazidime + ceftriaxone + cefepime + Pre-Pen + penicillin G + ampicillin + histamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cefazolin + cefuroxime + cefotaxime + ceftazidime + ceftriaxone + cefepime + Pre-Pen + penicillin G + ampicillin + histamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call